These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper. Weiner WJ; Nausieda PA; Klawans HL Neurology; 1978 Jul; 28(7):734-7. PubMed ID: 566875 [TBL] [Abstract][Full Text] [Related]
11. Lergotrile in the treatment of parkinsonism. Klawans HL; Goetz CG; Volkman P; Nausieda PA; Weiner WJ Neurology; 1978 Jul; 28(7):699-702. PubMed ID: 566868 [TBL] [Abstract][Full Text] [Related]
12. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism. Kartzinel R; Shoulson I; Calne DB Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655 [TBL] [Abstract][Full Text] [Related]
13. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism. Hutt CS; Snider SR; Fahn S Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299 [TBL] [Abstract][Full Text] [Related]
14. Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism. McLellan DL Br Med J; 1976 Jul; 2(6029):235-6. PubMed ID: 989742 [No Abstract] [Full Text] [Related]
15. Studies with bromocriptine. Part 1. "On-off" phenomena. Kartznel R; Calne DB Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489 [TBL] [Abstract][Full Text] [Related]
16. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors. Lew JY; Hata F; Ohashi T; Goldstein M J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229 [TBL] [Abstract][Full Text] [Related]
17. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients. Serby M; Angrist B; Lieberman A Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908 [No Abstract] [Full Text] [Related]
18. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. Parkes JD; Debono AG; Marsden CD J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999 [TBL] [Abstract][Full Text] [Related]
19. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Duvoisin RC; Heikkila RE; Manzino L Neurology; 1982 Dec; 32(12):1387-91. PubMed ID: 6128698 [TBL] [Abstract][Full Text] [Related]
20. Treatment of parkinson's disease with bromocriptine. Lieberman A; Kupersmith M; Estey E; Goldstein M N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]